| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| VCAM-1 | HOT VC1-H5253 | Human VCAM-1 / CD106 Protein, Fc Tag, premium grade | Human | HEK293 | ![]() | MALSSDS-PAGE | $300.00 100ug | |
| VCAM-1 | Human VCAM-1 / CD106 Protein, His Tag, low endotoxin (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $300.00 100ug | ||
| VCAM-1 | HOTAvitag VC1-H82F6 | Biotinylated Human VCAM-1 / CD106 Protein, Fc,Avitag™, premium grade | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | |
| VCAM-1 | HOTDMF GMP-VC1H25 | GMP Human VCAM-1 Protein, Fc Tag | Human | HEK293 | ![]() | SDS-PAGE | $545.00 100ug | |
| VCAM-1 | Cynomolgus VCAM-1 Protein, His Tag (MALS verified) | Cynomolgus | HEK293 | ![]() | MALSSDS-PAGE | $260.00 100ug | ||
| VCAM-1 | Avitag VC1-C82E3 | Biotinylated Cynomolgus VCAM-1 / CD106 Protein, His,Avitag™ (MALS verified) | Cynomolgus | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | |
| VCAM-1 | Avitag VC1-H83F3 | Biotinylated Human VCAM-1 / CD106 Protein, Fc,Avitag™, premium grade (CHO) | Human | CHO | ![]() | MALSSDS-PAGE | $360.00 25ug | |
| VCAM-1 | Mouse VCAM-1 / CD106 Protein, His Tag (MALS verified) | Mouse | HEK293 | ![]() | MALSSDS-PAGE | $260.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| 99mTc-cAbVCAM1-5 | 99mTccAbVCAM1‐5; 99mTc-cAbVCAM1-5 | Phase 1 Clinical | Medico-Economic Evaluation Unit , University Hospital, Grenoble | Atherosclerosis; Cardiovascular Diseases | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Tocopherol acetate | DSE-9912 | Approved | National Institute Of Diabetes And Digestive And Kidney Diseases | Ephynal, Aquasol E | Japan | Vitamin E Deficiency; Diabetic Retinopathy; Atherosclerosis; Intermittent Claudication; Venous Thromboembolism; Thrombosis | Eisai Co Ltd | 1951-09-01 | Atherosclerosis; Diabetic Retinopathy; Intermittent Claudication; Metabolic Dysfunction-Associated Steatotic Liver Disease; Thrombosis; Venous Thromboembolism; Vitamin E Deficiency | Details |
| Ascorbic Acid/Biotin/Cholecalciferol/Cyanocobalamin/Dexpanthenol/Folic acid/Niacinamide/Pyridoxine/Riboflavin/Thiamine/Tocopherol Acetate/Vitamin A/Vitamin K | Approved | Sandoz Canada Inc | Infuvite Pediatric | United States | Avitaminosis | Sandoz Canada Inc | 2001-02-21 | Avitaminosis | Details |